The Effects of Acarbose on Non-Diabetic Overweight and Obese Patients: A Meta-Analysis

ConclusionAcarbose monotherapy is beneficial in reducing TG levels in obese or overweight patients and will not result in hypoglycemia during medication. The side effects of acarbose are mild.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research